Splinting vs Exercise in De Quervain's Tenosynovitis
Comparison of Static Hand-Wrist Splinting and Exercise Therapy in the Management of De Quervain's Tenosynovitis
1 other identifier
interventional
40
1 country
1
Brief Summary
De Quervain's disease is a painful tenosynovitis of the abductor pollicis longus and extensor pollicis brevis muscle tendons located in the first dorsal compartment. The primary treatment for De Quervain's disease is conservative; surgical intervention is rarely required. Currently, there is no standardized treatment protocol supported by strong, up-to-date evidence. The aim of this study is to compare the effectiveness of a static hand-wrist resting splint and exercise therapy in the conservative treatment of De Quervain's tenosynovitis. Patients will be evaluated in terms of pain levels, functional/symptom status, hand-finger strength, pressure pain threshold (PPT), tendon cross-sectional area measured by ultrasound, and the presence of effusion findings (semiquantitative; 0-3), and patient satisfaction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 12, 2025
CompletedFirst Posted
Study publicly available on registry
May 29, 2025
CompletedStudy Start
First participant enrolled
May 29, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2026
CompletedMarch 24, 2026
March 1, 2026
10 months
May 12, 2025
March 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
VAS pain
VAS pain activity and rest: 0 no pain; 10 unbearable/max. pain.
baseline, week 2 and week 6
Patient Rated Wrist Evaluation( PRWE)
The Patient-Rated Wrist Evaluation (PRWE) is a brief and effective self-report questionnaire that allows patients to assess their own wrist and hand problems. The PRWE consists of two main subscales: the Pain Subscale (0-50 points) and the Function Subscale (0-50 points). The total score ranges from 0 (no disability) to 100 (maximum pain and functional impairment).
baseline, week 2 and week 6
The Disabilities of the Arm, Shoulder and Hand (DASH)
The Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire is a self-reported outcome measure used to assess the impact of upper extremity disorders on daily activities. It consists of 30 items, each scored on a 5-point Likert scale ranging from 1 (no difficulty) to 5 (unable to perform). The total score ranges from 0 to 100, where 0 indicates no disability and 100 indicates severe functional limitation.
baseline, week 2 and week 6
Secondary Outcomes (4)
Hand grip strength
baseline, week 2 and week 6
Finger pinch strength
baseline, week 2 and week 6
Ultrasonographic evaluation of the first dorsal compartment tendons
Baseline, week 2 and week 6
Patient satisfaction
week 2 and week 6
Study Arms (2)
Static Hand-Wrist Splinting
OTHERExercise Therapy
OTHERInterventions
static wrist-hand splint + education on activity modification and positioning in daily life
Home-based Exercise Therapy + Education on activity modification and positioning in daily life
Eligibility Criteria
You may qualify if:
- Adults aged between 18 and 65 years
- Patients experiencing wrist pain and tenderness for less than 3 months and clinically diagnosed with acute or subacute De Quervain's tenosynovitis
- Visual Analog Scale (VAS) pain score ≥ 3
You may not qualify if:
- History of trauma
- Wrist fractures
- Local infection
- Presence of rheumatologic diseases (e.g., rheumatoid arthritis, psoriatic arthritis)
- Presence of symptomatic hand osteoarthritis
- Continuous use of nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids
- Receipt of physical therapy for the hand or wrist within the past 3 months
- Corticosteroid injection into the hand or wrist within the past 3 months
- Diagnosed with significant neurological disorders (e.g., upper motor neuron disease)
- Presence of uncontrolled systemic diseases (e.g., uncontrolled diabetes mellitus, congestive heart failure, chronic kidney disease, hepatic failure)
- Major psychiatric disorders
- Communication difficulties
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Konya Beyhekim Training and Research Hospital
Konya, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- doctor
Study Record Dates
First Submitted
May 12, 2025
First Posted
May 29, 2025
Study Start
May 29, 2025
Primary Completion
April 1, 2026
Study Completion
April 30, 2026
Last Updated
March 24, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share